<DOC>
	<DOC>NCT00578695</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.</brief_summary>
	<brief_title>THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<criteria>Male and female patients 18 years of age or older with hyponatremia and hospitalized for congestive heart failure.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Hyponatremia</keyword>
	<keyword>Serum Sodium</keyword>
	<keyword>Fluid Overload</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Acute Heart Failure</keyword>
	<keyword>Vasopressin Antagonist</keyword>
</DOC>